CG
AVNS

Cutler Group’s Avanos Medical AVNS Stock Holding History

Cutler Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,725
Closed -$255K – 3907
2018
Q3 		$255K Buy
+3,725
New +$240K 0.02% 723
2017
Q4 		– Sell
-40
Closed -$1K – 4872
2017
Q3 		$1K Sell
40
-85
-68% -$3.63K ﹤0.01% 5331
2017
Q2 		$4K Sell
125
-2,368
-95% -$89.5K ﹤0.01% 4975
2017
Q1 		$94K Sell
2,493
-200
-7% -$7.79K ﹤0.01% 1792
2016
Q4 		$99K Sell
2,693
-4,165
-61% -$149K ﹤0.01% 1912
2016
Q3 		$237K Buy
6,858
+2,800
+69% +$98.1K 0.01% 1072
2016
Q2 		$131K Buy
4,058
+1,975
+95% +$60.5K 0.01% 1457
2016
Q1 		$59K Buy
2,083
+1,837
+747% +$48.9K ﹤0.01% 2145
2015
Q4 		$8K Buy
+246
New +$7.65K ﹤0.01% 4355

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cutler Group's AVNS Position: Q4 2018 in Review

Cutler Group sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,725 shares — an estimated $255K sold.

Cutler Group first reported a position in AVNS in Q4 2015 and held it in 9 quarters. The position peaked at $255K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Cutler Group reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Cutler Group sold 3,725 Avanos Medical shares in Q4 2018, an estimated $255K.
  • Cutler Group first reported a position in Avanos Medical in Q4 2015 and held it in 9 quarters.
  • Cutler Group's Avanos Medical position peaked at $255K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Cutler Group's 13F filing for Q4 2018, filed 5 Feb 2019.